Tiprelestat for treatment of hospitalized COVID-19: results of the double-blind randomized placebo-controlled COMCOVID trial. - Bergs I; Budweiser S; Henneicke-von Zepelin HH; Kelm H; Bollmann T; Tebbe JJ; Sorichter S; Lüth S; Walterspacher S; Wege H; Wiedow O; Dreher M (Advances in therapy, 2025)